News | March 22, 2022
Hester Biosciences foray into pet care industry
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
An MoU was signed between B Medical Systems and Gujarat government recently
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
CDSCO to fast-track trials and approval for COVID19 vaccine
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
